{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:50:32Z","timestamp":1770040232459,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":5035,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.jpainsymman.2005.08.013","type":"journal-article","created":{"date-parts":[[2006,4,24]],"date-time":"2006-04-24T23:42:40Z","timestamp":1145922160000},"page":"317-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Efficacy of Darbepoetin Alfa in Alleviating Fatigue and the Effect of Fatigue on Quality of Life in Anemic Patients with Lymphoproliferative Malignancies"],"prefix":"10.1016","volume":"31","author":[{"given":"Timothy J.","family":"Littlewood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel D.","family":"Kallich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hedenus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jpainsymman.2005.08.013_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1634\/theoncologist.8-suppl_1-19","article-title":"Anemia in cancer: some pathophysiological aspects","volume":"8","author":"Dicato","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/ctrv.2000.0181","article-title":"Anemia in cancer: pathophysiology and treatment","volume":"26","author":"Mercadante","year":"2000","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib3","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.11186","article-title":"A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease","volume":"97","author":"Glaspy","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archinte.1978.03630270051019","article-title":"Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma","volume":"138","author":"Cabanillas","year":"1978","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.jpainsymman.2005.08.013_bib5","first-page":"S2","article-title":"The impact and management of anemia in haematological malignancies","volume":"17","author":"Coiffier","year":"2000","journal-title":"Med Oncol"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib6","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood.V83.6.1499.bloodjournal8361499","article-title":"Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin","volume":"83","author":"Leonard","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib7","first-page":"497a","article-title":"Early treatment with epoetin alfa improves anemia, quality of life (QOL), and productivity in patients (pts) with hematologic malignancies and mild anemia during chemotherapy (CT)","volume":"102","author":"Straus","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199006143222401","article-title":"Decreased erythropoietin response in patients with the anemia of cancer","volume":"322","author":"Miller","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib9","first-page":"109","article-title":"Physical function in men and women with cancer. Effects of anemia and conditioning","volume":"16","author":"Evans","year":"2002","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib10","first-page":"20","article-title":"Fatigue in cancer patients: a review of the literature","volume":"4","author":"Richardson","year":"1995","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib11","first-page":"369","article-title":"Progress toward guidelines for the management of fatigue","volume":"12","author":"Cella","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000061296","article-title":"Efficacy and quality of life outcomes of epoetin-alpha in a double-blind, placebo-controlled, multicentre study of cancer patients receiving non-platinum-containing chemotherapy","volume":"37","author":"Littlewood","year":"2002","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/cncr.11463","article-title":"The relationship between psychologic distress and cancer-related fatigue","volume":"98","author":"Tchekmedyian","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib14","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/94.16.1211","article-title":"Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy","volume":"94","author":"Vansteenkiste","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib15","first-page":"S2","article-title":"Erythropoietin for anemia in cancer patients","volume":"29A","author":"Abels","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/jnci\/85.10.801","article-title":"Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy","volume":"85","author":"Case","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/sj.bjc.6600465","article-title":"Darbepoetin alfa given every 1 or 2 weeks alleviates anemia associated with cancer chemotherapy","volume":"87","author":"Glaspy","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib18","unstructured":"National Comprehensive Cancer Network, Inc. Cancer and treatment-related anemia. NCCN\u00ae practice guidelines in oncology\u2014Version 1. 2004."},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/stem.5530110203","article-title":"Recombinant human erythropoietin and the anemia of multiple myeloma","volume":"11","author":"Barlogie","year":"1993","journal-title":"Stem Cells"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2141.2001.02715.x","article-title":"Efficacy of epoetin alfa in the treatment of anemia of multiple myeloma","volume":"113","author":"Dammacco","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib21","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/archinte.1995.00430190059008","article-title":"Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial","volume":"155","author":"Garton","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib22","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJM199006143222402","article-title":"Erythropoietin treatment of anemia associated with multiple myeloma","volume":"322","author":"Ludwig","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000203625","article-title":"Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia","volume":"98","author":"Mittelman","year":"1997","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.bjc.6600801","article-title":"Impact of epoetin beta on quality of life in patients with malignant disease","volume":"88","author":"Boogaerts","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib25","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.2002.08.131","article-title":"Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies","volume":"20","author":"Osterborg","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2141.2003.04448.x","article-title":"Efficacy and safety of darbepoetin alfa in anemic patients wth lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study","volume":"122","author":"Hedenus","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib27","first-page":"13","article-title":"The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue","volume":"34","author":"Cella","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib29","series-title":"Brief Symptom Inventory administration, scoring and procedures manual","author":"Derogatis","year":"1993"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","article-title":"Combining anchor and distribution based methods to derive clinically meaningful differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales","volume":"24","author":"Cella","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1015276414526","article-title":"Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening","volume":"11","author":"Cella","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cncr.10245","article-title":"Fatigue in cancer patients compared with fatigue in the general United States population","volume":"94","author":"Cella","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib33","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cncr.10763","article-title":"Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy","volume":"95","author":"Crawford","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2005.08.013_bib34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1200\/JCO.2003.02.136","article-title":"Epoetin alfa treatment results in clinically significant improvements when referenced to the general population","volume":"21","author":"Cella","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392406000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392406000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:57:03Z","timestamp":1760129823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392406000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0885392406000467"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.08.013","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Darbepoetin Alfa in Alleviating Fatigue and the Effect of Fatigue on Quality of Life in Anemic Patients with Lymphoproliferative Malignancies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}